The Bottom LinePart of A Guide to Fuzeon: The First Fusion Inhibitor
January 2005 Fuzeon, the first approved fusion inhibitor, represents just one of what we hope will be many new classes of HIV meds. Each new class of meds provides a unique means of fighting HIV, and gives hope to people who are running out of treatment options. Like any other HIV medication, though, Fuzeon isn't a cure, and it can't do the job all by itself. Although it works differently from other HIV meds, and needs to be injected, ultimately, it is just another HIV medication. This means that for it to work best, Fuzeon needs to be taken with other HIV meds. When it is, it can keep the HIV in your body at bay for a long time -- possibly many years -- and help your immune system rebuild itself. Fuzeon also has many of the same vulnerabilities that all HIV medications have. HIV can develop resistance to it (especially if you often forget to take all of your doses on time), and it does have side effects, although those side effects are generally milder than those of many other HIV meds. Stay healthy, and thank you for reading! Copyright © 2005 Body Health Resources Corporation. All rights reserved. This article was provided by The Body. It is a part of the publication A Guide to Fuzeon: The First Fusion Inhibitor. |
|